Nine Chapters Capital Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Nine Chapters Capital Management’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,290	Closed	-$23K	–	761
2015 Q3	$23K	Sell	1,290 -1,320	-51%	-$34.7K	﹤0.01%	962
2015 Q2	$77K	Buy	+2,610	New	+$78.9K	0.01%	890

Other funds holding IPCI

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nine Chapters Capital Management's IPCI Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q4 2015, closing a stake of 1,290 shares — an estimated $23K sold.

Nine Chapters Capital Management first reported a position in IPCI in Q2 2015 and held it in 2 quarters. The position peaked at $77K in Q2 2015. 16 funds tracked by Wall St. Rank hold IPCI as of Q4 2015.

Nine Chapters Capital Management reported no remaining Intellipharmaceuticals International Inc. position as of Q4 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 1,290 Intellipharmaceuticals International Inc. shares in Q4 2015, an estimated $23K.
Nine Chapters Capital Management first reported a position in Intellipharmaceuticals International Inc. in Q2 2015 and held it in 2 quarters.
Nine Chapters Capital Management's Intellipharmaceuticals International Inc. position peaked at $77K in Q2 2015.
16 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.